Form D · Biotechnology

VISEN MEDICAL INC

Bedford, MA · CIK 0001130651

Offering snapshot reported Oct 8, 2009 · SEC filing

Reported sold
$885K
Offering amount: $4.25M
Investors reported
23
Form D · investor count
Minimum accepted
$12
Reported outside-investor minimum
First sale
Sep 24, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 8, 2009Initial$885,418No comparison23SEC filing
Feb 18, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Oct 15, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Aug 31, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Jun 28, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-49818
Investors have agreed, pursuant to the terms of the Stock Purchase Agreement, to acquire amounts remaining to be sold in two (2) additional tranches.

Source: Form D, filed Oct 8, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ed Kania Director
Per G. H. Lofberg Director
Kirtland Poss Director, Executive
Erik Wallden Director
Ralph Weissleder, Ph.D. Director
John Ziolkowski Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
45 Wiggins Avenue
Bedford, MA, 01730